These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10714952)

  • 1. Comparison of the vasorelaxing effect of cromakalim and the new inodilator, levosimendan, in human isolated portal vein.
    Pataricza J; Hõhn J; Petri A; Balogh A; Papp JG
    J Pharm Pharmacol; 2000 Feb; 52(2):213-7. PubMed ID: 10714952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional role of potassium channels in the vasodilating mechanism of levosimendan in porcine isolated coronary artery.
    Pataricza J; Krassói I; Höhn J; Kun A; Papp JG
    Cardiovasc Drugs Ther; 2003 Mar; 17(2):115-21. PubMed ID: 12975592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levosimendan interacts with potassium channel blockers in human saphenous veins.
    Höhn J; Pataricza J; Petri A; Tóth GK; Balogh A; Varró A; Papp JG
    Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):271-3. PubMed ID: 15228498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of potassium channels in the vasodilatory effect of levosimendan in human internal thoracic arteries.
    Usta C; Eksert B; Gölbasi I; Bigat Z; Ozdem SS
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):329-32. PubMed ID: 16829109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes.
    Yokoshiki H; Katsube Y; Sunagawa M; Sperelakis N
    Eur J Pharmacol; 1997 Aug; 333(2-3):249-59. PubMed ID: 9314042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of potassium channels in relaxant effect of levosimendan in rat small mesenteric arteries.
    Ozdem SS; Yalcin O; Meiselman HJ; Baskurt OK; Usta C
    Cardiovasc Drugs Ther; 2006 Apr; 20(2):123-7. PubMed ID: 16554965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levosimendan increases diastolic coronary flow in isolated guinea-pig heart by opening ATP-sensitive potassium channels.
    Kaheinen P; Pollesello P; Levijoki J; Haikala H
    J Cardiovasc Pharmacol; 2001 Apr; 37(4):367-74. PubMed ID: 11300649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary vasorelaxant effect of levosimendan, a new inodilator with calcium-sensitizing properties.
    Gruhn N; Nielsen-Kudsk JE; Theilgaard S; Bang L; Olesen SP; Aldershvile J
    J Cardiovasc Pharmacol; 1998 May; 31(5):741-9. PubMed ID: 9593074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of potassium channels in the relaxant effect of levosimendan in guinea pig tracheal preparations.
    Eksert B; Usta C
    Pharmacol Rep; 2009; 61(2):275-80. PubMed ID: 19443939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potassium channel-related relaxation by levosimendan in the human internal mammary artery.
    Yildiz O; Seyrek M; Yildirim V; Demirkilic U; Nacitarhan C
    Ann Thorac Surg; 2006 May; 81(5):1715-9. PubMed ID: 16631661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potassium channels in the vasodilating action of levosimendan on the human umbilical artery.
    Yildiz O; Nacitarhan C; Seyrek M
    J Soc Gynecol Investig; 2006 May; 13(4):312-5. PubMed ID: 16697949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The levosimendan metabolite OR-1896 elicits vasodilation by activating the K(ATP) and BK(Ca) channels in rat isolated arterioles.
    Erdei N; Papp Z; Pollesello P; Edes I; Bagi Z
    Br J Pharmacol; 2006 Jul; 148(5):696-702. PubMed ID: 16715115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levosimendan is a mitochondrial K(ATP) channel opener.
    Kopustinskiene DM; Pollesello P; Saris NE
    Eur J Pharmacol; 2001 Oct; 428(3):311-4. PubMed ID: 11689188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Novel Inodilator ORM-3819 Relaxes Isolated Porcine Coronary Arteries: Role of Voltage-Gated Potassium Channel Activation.
    Márton Z; Pataricza J; Pollesello P; Varró A; Papp JG
    J Cardiovasc Pharmacol; 2019 Sep; 74(3):218-224. PubMed ID: 31356552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasodilating mechanisms of levosimendan: involvement of K+ channels.
    Yildiz O
    J Pharmacol Sci; 2007 May; 104(1):1-5. PubMed ID: 17452812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel calcium sensitizer levosimendan activates the ATP-sensitive K+ channel in rat ventricular cells.
    Yokoshiki H; Katsube Y; Sunagawa M; Sperelakis N
    J Pharmacol Exp Ther; 1997 Oct; 283(1):375-83. PubMed ID: 9336346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levosimendan and its metabolite OR-1896 elicit KATP channel-dependent dilation in resistance arteries in vivo.
    Gödény I; Pollesello P; Edes I; Papp Z; Bagi Z
    Pharmacol Rep; 2013; 65(5):1304-10. PubMed ID: 24399726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KATP-channel-induced vasodilation is modulated by the Na,K-pump activity in rabbit coronary small arteries.
    Glavind-Kristensen M; Matchkov V; Hansen VB; Forman A; Nilsson H; Aalkjaer C
    Br J Pharmacol; 2004 Dec; 143(7):872-80. PubMed ID: 15504751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasodilating mechanisms of levosimendan.
    Yokoshiki H; Sperelakis N
    Cardiovasc Drugs Ther; 2003 Mar; 17(2):111-3. PubMed ID: 14562823
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of age on the vasorelaxation elicited by cromakalim. Role of K+ channels and cyclic GMP.
    Ferrer M; Tejera N; Marín J; Balfagón G
    Life Sci; 1998; 63(23):2071-8. PubMed ID: 9839530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.